Literature DB >> 10632911

Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy.

M Reyle-Hahn1, B Niggemann, M Max, R Streich, R Rossaint.   

Abstract

Flexible fibreoptic bronchoscopy (FOB) has become a useful diagnostic and therapeutic procedure in children. We investigated 26 patients (3-14 years) for FOB using a new sedation strategy. All patients received oral premedication and inhalation of topical anaesthetic. Sedation for bronchoscopy was achieved with a continuous infusion of remifentanil and intermittent boluses of propofol. Propofol injection was repeated if sedation was inadequate. Sedation could be successfully performed in all children without adverse effects. Endtidal CO2 concentration and arterial oxygen saturation remained stable throughout the study. All children were awake 5+/-1.3 min after stopping remifentanil infusion. Sedation with remifentanil/propofol is a new sedation strategy for diagnostic flexible paediatric bronchoscopy in children with spontaneous ventilation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632911     DOI: 10.1046/j.1460-9592.2000.00440.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  9 in total

Review 1.  Bronchoscopist talks to you.

Authors:  A Balachandran; D Vijayasekaran; So Shivbalan
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

2.  Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department.

Authors:  M J G Dunn; R Mitchell; C D Souza; G Drummond
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

Review 3.  Sedation and analgesia for brief diagnostic and therapeutic procedures in children.

Authors:  Sascha Meyer; Ulrich Grundmann; Sven Gottschling; Stefan Kleinschmidt; Ludwig Gortner
Journal:  Eur J Pediatr       Date:  2007-01-05       Impact factor: 3.183

Review 4.  Experience with remifentanil in neonates and infants.

Authors:  Lars Welzing; Bernhard Roth
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Remifentanil update: clinical science and utility.

Authors:  Richard Beers; Enrico Camporesi
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Dexmedetomidine-fentanyl versus propofol-fentanyl in flexible bronchoscopy: A randomized study.

Authors:  Feng Yuan; Hongguang Fu; Pengju Yang; Kai Sun; Shubiao Wu; Miaomiao Lv; Zhenzhen Dong; Tieli Dong
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

7.  Analgosedation during flexible fiberoptic bronchoscopy: comparing the clinical effectiveness and safety of remifentanil versus midazolam/propofol.

Authors:  Hyun Lee; Yeong Hun Choe; Seungyong Park
Journal:  BMC Pulm Med       Date:  2019-12-09       Impact factor: 3.317

8.  Effectiveness of high dose remifentanil in preventing coughing and laryngospasm in non-paralyzed patients for advanced bronchoscopic procedures.

Authors:  Basavana Gouda Goudra; Preet Mohinder Singh; Amit K Manjunath; Joel W Reihmer; Andrew R Haas; Anthony R Lanfranco; Ashish C Sinha; Kassem Harris
Journal:  Ann Thorac Med       Date:  2014-01       Impact factor: 2.219

Review 9.  Anaesthesia for bronchoscopy.

Authors:  Meenu Chadha; Mayank Kulshrestha; Alok Biyani
Journal:  Indian J Anaesth       Date:  2015-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.